Literature DB >> 11368536

NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.

V E Mack Strong1, P J Mackrell, E M Concannon, J R Mestre, G P Smyth, P A Schaefer, P P Stapleton, J M Daly.   

Abstract

Prostaglandin E(2) (PGE(2)) production after trauma contributes to immune alterations that increase susceptibility to infections. We hypothesize that blocking PGE(2) with NS-398, a selective COX-2 inhibitor, will modulate this response and improve outcome. This study evaluated the effect of NS-398 given over 7 days on proinflammatory cytokines, intracellular signaling, and survival after a septic challenge. Balb/C mice (n = 8/group) were given 10 mg/kg NS-398 intraperitoneally over 7 days, starting after anesthesia or trauma (femur fracture + 40% hemorrhage). Four groups, anesthesia + vehicle (C), anesthesia + NS-398 (CN), trauma + vehicle (T), or trauma + NS-398 (TN), were studied. On Day 7 after trauma, mice were sacrificed, serum was collected, and splenic macrophages were evaluated for PGE(2), LTB(4), IL-6, TNF-alpha, and NO production. Additionally, macrophage COX-2 mRNA, IkappaB-alpha, and NF-kappaB were evaluated. In a separate study, mice (n = 10-11/group) were traumatized and given NS-398 over 7 days, and then cecal ligation and puncture (CLP) were performed. Mice were then followed for survival over 10 days (via log-rank test). NS-398 treatment of injured mice decreased PGE(2) production compared to T (3.9 +/- 0.3 vs 3.1 +/- 0.4 pg/microg protein), and significantly decreased IL-6, NO, and TNF-alpha production. NS-398 treatment also attenuated COX-2 mRNA levels and NF-kappaB activation. These cellular events correlate with a significant survival advantage in TN versus T mice after CLP. These data suggest that a specific COX-2 inhibitor not only suppresses PGE(2), but normalizes proinflammatory cytokines after trauma through changes that may partly be mediated via transcriptional events. This correlates with significantly increased survival in TN mice given a septic challenge and suggests that COX-2 inhibitors contribute to modulating the inflammatory response and improving survival after trauma. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368536     DOI: 10.1006/jsre.2001.6154

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment.

Authors:  Manuel Lima-Rodrigues; Nuno Lamas; Ana Valle-Fernandes; Andrea Cruz; Artur Vieira; Pedro Oliveira; Jorge Pedrosa; António G Castro; Rui M Reis; Fátima Baltazar; Armando Almeida
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

2.  ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences.

Authors:  Salvador Aznar Benitah; Pilar F Valerón; Juan Carlos Lacal
Journal:  Mol Biol Cell       Date:  2003-07       Impact factor: 4.138

Review 3.  Pathoanatomy and clinical correlates of the immunoinflammatory response following orthopaedic trauma.

Authors:  Benjamin W Sears; Michael D Stover; John Callaci
Journal:  J Am Acad Orthop Surg       Date:  2009-04       Impact factor: 3.020

4.  Transcriptional Modulation of the Hippo Signaling Pathway by Drugs Used to Treat Bipolar Disorder and Schizophrenia.

Authors:  Bruna Panizzutti; Chiara C Bortolasci; Briana Spolding; Srisaiyini Kidnapillai; Timothy Connor; Mark F Richardson; Trang T T Truong; Zoe S J Liu; Gerwyn Morris; Laura Gray; Jee Hyun Kim; Olivia M Dean; Michael Berk; Ken Walder
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

5.  Effects of trauma-hemorrhage and IL-6 deficiency on splenic immune function in a murine trauma model.

Authors:  P Mommsen; T Barkhausen; C Zeckey; H Andruszkow; C Krettek; C Neunaber
Journal:  Mediators Inflamm       Date:  2012-02-09       Impact factor: 4.711

6.  Stellera chamaejasme and its constituents induce cutaneous wound healing and anti-inflammatory activities.

Authors:  Myungsuk Kim; Hee Ju Lee; Ahmad Randy; Ji Ho Yun; Sang-Rok Oh; Chu Won Nho
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

Review 7.  Lipid mediators in immune dysfunction after severe inflammation.

Authors:  James N Fullerton; Alastair J O'Brien; Derek W Gilroy
Journal:  Trends Immunol       Date:  2013-11-21       Impact factor: 16.687

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.